Will Fewer PSA Screenings Lead To More Prostate Cancer Deaths?

Will Fewer PSA Screenings Lead To More Prostate Cancer Deaths?
Two recent studies revealed that fewer men are undergoing PSA tests, which raises the question: Will there be more men dying from prostate cancer in the future as a result? In a 2015 news release, Dr. David Samadi, chairman of urology and chief of robotic surgery at Lenox Hill Hospital in New York, said that despite efforts to push for early detection, prostate cancer was still expected to cause 27,500 deaths in the U.S. in 2015 alone. "Tens of thousands of additional men suffer from the burden of painful metastatic prostate cancer, which can lead to bone fractures, the inability to urinate, spinal cord compression and renal failure. The evidence remains that since PSA screening became widely recognized in the early 1990s, there has been a 39 percent reduction in prostate cancer mortality rates," Samadi said in the release. Still, not everyone agrees with Samadi's findings, and some believe that fewer PSA tests will not lead to increased prostate cancer related deaths. Dr. Kenneth Lin, a family medicine physician at Georgetown University School of Medicine, said believing that less PSA testing will lead to more death,  is based on  "putting all your faith" on the results of one study that found a mortality benefit from PSA testing. "It's not right to ignore the other trials," Dr Lin said, noting that non-cited studies reveal that PSA blood tests save men's lives as well. PSA testing for prostate cancer screening has been a subject of debate for many years. A decade ago, evidence began revealing that PSA screening led to over-diagnosis and over-treatment. Elevated blood PSA levels in the blood can be indicative
Subscribe or to access all post and page content.